Corvus Pharmaceuticals, Inc. - Common Stock (CRVS)
5.4950
+0.2050 (3.88%)
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the development of innovative therapies for the treatment of cancer
The company is primarily engaged in the discovery and development of immuno-oncology products, aiming to harness the body’s immune system to fight against various types of tumors. Corvus leverages its expertise in biologic compounds to create targeted treatments that enhance immune response while minimizing side effects. Through its ongoing research and clinical trials, the company seeks to provide new options for patients with unmet medical needs in oncology.
Frequently Asked Questions
Is Corvus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Corvus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Corvus Pharmaceuticals, Inc. - Common Stock trade on?
Corvus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock is CRVS on the Nasdaq Stock Market
What is the current price of Corvus Pharmaceuticals, Inc. - Common Stock?
The current price of Corvus Pharmaceuticals, Inc. - Common Stock is 5.495
When was Corvus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Corvus Pharmaceuticals, Inc. - Common Stock was at 11:31 am EST on January 31st, 2025
What is the market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock is 353.09M
How many shares of Corvus Pharmaceuticals, Inc. - Common Stock are outstanding?
Corvus Pharmaceuticals, Inc. - Common Stock has 64.26M shares outstanding.